China Medicine Corporation
CHMEOTCHealthcare● Active
$0.03
+$0.01(+60.00%)
Market Cap$758786
P/E Ratio—
52W High$0.042
52W Low$0.0002
China Medicine Corporation (CHME) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CHME · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2009-12 | 2008-12 | 2007-12 | 2006-12 | 2005-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $64.75M | $53.65M | $42.11M | $23.99M | $0.00M |
| Cost of Revenue | $45.77M | $38.07M | $29.71M | $15.02M | $0.00M |
| Gross Profit | $18.98M | $15.57M | $12.40M | $8.97M | $0.00M |
| Gross Margin %(computed) | 29.32% | 29.03% | 29.44% | 37.41% | — |
| Operating Expenses | |||||
| R&D Expenses | $1.45M | $0.84M | $0.65M | $0.29M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $6.72M | $4.65M | $3.98M | $2.79M | $0.03M |
| Operating Income | $12.27M | $10.93M | $8.41M | $6.18M | ($0.03M) |
| Operating Margin %(computed) | 18.94% | 20.37% | 19.98% | 25.78% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $4.95M | $11.01M | $8.43M | $5.98M | $0.00M |
| Income Tax Expense | $3.55M | $2.01M | $1.65M | $1.23M | $0.03M |
| Net Income | $1.72M | $9.13M | $6.88M | $4.79M | ($0.03M) |
| Net Margin %(computed) | 2.65% | 17.01% | 16.33% | 19.96% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.11 | $0.60 | $0.56 | $0.65 | $-0.01 |
| Wtd Avg Shares | 15.27M | 15.17M | 12.35M | 7.35M | 6.53M |
| EBITDA | $13.28M | $11.35M | $9.20M | $6.35M | ($0.03M) |
| EBITDA Margin %(computed) | 20.51% | 21.15% | 21.85% | 26.45% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more China Medicine Corporation data
About China Medicine Corporation (CHME) Income Statement
China Medicine Corporation (CHME) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2009, CHME reported revenue of $0.06B, gross profit of $0.02B (gross margin 29.32%), and net income of $0.00B — a net profit margin of 2.65%.
Frequently asked questions
CHME · 4 questionsChina Medicine Corporation (CHME) reported revenue of $0.06B for 2009, up 20.7% year-over-year.
CHME revenueCHME salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09